Значение20202021202220232024TTMДенежный поток от инвестиционной деятельности-42.88 M-524.41 M-26.95 M-116.78 M350.44 M350.44 MДенежный поток от финансовой деятельности-14.8 M586 K-546.05 M-628.81 M-969.59 M-969.59 MСвободный денежный поток336.58 M334.91 M292.86 M671.54 M875.84 M875.84 M
Exelixis Inc
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.